
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.45 | 0.45 | 0.00 |
Shares | 99.55 | 99.55 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.88 | 18.92 |
Price to Book | 3.49 | 4.33 |
Price to Sales | 2.51 | 2.37 |
Price to Cash Flow | 14.28 | 15.54 |
Dividend Yield | 1.66 | 1.18 |
5 Years Earnings Growth | 14.78 | 10.49 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 96.63 | 99.59 |
Financial Services | 1.92 | 0.84 |
Communication Services | 0.69 | 0.75 |
Consumer Defensive | 0.60 | 0.48 |
Basic Materials | 0.12 | 1.02 |
Technology | 0.04 | 0.18 |
Number of long holdings: 110
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.50 | 731.96 | -0.30% | |
Boston Scientific | US1011371077 | 5.35 | 105.75 | -0.11% | |
UnitedHealth | US91324P1021 | 4.90 | 302.29 | -0.52% | |
Regeneron Pharma | US75886F1075 | 4.46 | 579.61 | -1.25% | |
Merck&Co | US58933Y1055 | 4.17 | 83.21 | -1.02% | |
Pfizer | US7170811035 | 4.11 | 24.60 | -1.87% | |
Chugai Pharmaceutical | JP3519400000 | 3.96 | 6,580.0 | +1.54% | |
AbbVie | US00287Y1091 | 3.69 | 207.92 | -0.07% | |
Amgen | US0311621009 | 3.66 | 285.61 | -0.82% | |
Roche Holding Participation | CH0012032048 | 3.62 | 261.00 | -0.61% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Delaware Small Cap Core I | 4.98B | -2.80 | 5.49 | 7.75 | ||
Delaware Emerging Markets Instl | 3.18B | 28.05 | 15.15 | 8.66 | ||
Optimum Large Cap Growth Instl | 2.01B | 7.08 | 20.58 | 13.35 | ||
Delaware Small Cap Value Instl | 1.94B | 0.46 | 5.94 | 7.59 | ||
Optimum Large Cap Value Instl | 1.88B | 6.36 | 10.55 | 8.79 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review